Current
Neuro-Oncology


Volume 21 Number 8
August 2019


Home > Disciplines > Publications > Current Neuro-Oncology > Volume 21, Year 2019 > Number 8, August


CONTENTS


CENTRAL NERVOUS SYSTEM TUMORS

GLIOMAS
HIGH-GRADE GLIOMAS
GLIOMATOSIS CEREBRI
LOW-GRADE GLIOMAS

DIFFUSE ASTROCYTIC AND OLIGODENDROGLIAL TUMORS
GLIOBLASTOMA





CENTRAL NERVOUS SYSTEM TUMORS

.

Michaud L, Beattie BJ, Akhurst T, Dunphy M, Zanzonico P, Finn R, Mauguen A, Schöder H, Weber WA, Lassman AB, Blasberg R.
18F-Fluciclovine (18F-FACBC) PET imaging of recurrent brain tumors.
Eur J Nucl Med Mol Imaging. 2019 Aug 15. doi: 10.1007/s00259-019-04433-1. [Epub ahead of print] Erratum .
Source . Similar articles



.

Vidart d'Egurbide Bagazgoïtia N, Bailey HD, Orsi L, Guerrini-Rousseau L, Bertozzi AI, Faure-Conter C, Leblond P, Pellier I, Freycon C, Doz F, Puget S, Ducassou S, Lacour B, Clavel J.
Family history of cancer and the risk of childhood brain tumors: a pooled analysis of the ESCALE and ESTELLE studies (SFCE).
Cancer Causes Control. 2019 Oct;30(10):1075-1085. doi: 10.1007/s10552-019-01214-x. Epub 2019 Aug 9.
Source . Similar articles



GLIOMAS

.

Bukhari SS, Shamim MS, Mubarak F.
Timing of postoperative magnetic resonance imaging (MRI) following glioma resection: Shattering the 72 hour window.
J Pak Med Assoc. 2019 Aug;69(8):1224-1225.
Source . Similar articles



.

Kim D, Wang N, Ravikumar V, Raghuram DR, Li J, Patel A, Wendt RE 3rd, Rao G, Rao A.
Prediction of 1p/19q Codeletion in Diffuse Glioma Patients Using Pre-operative Multiparametric Magnetic Resonance Imaging.
Front Comput Neurosci. 2019 Jul 30;13:52. doi: 10.3389/fncom.2019.00052. eCollection 2019.
Source . Similar articles



.

Kong Z, Lin Y, Jiang C, Li L, Liu Z, Wang Y, Dai C, Liu D, Qin X, Wang Y, Liu Z, Cheng X, Tian J, Ma W.
18F-FDG-PET-based Radiomics signature predicts MGMT promoter methylation status in primary diffuse glioma.
Cancer Imaging. 2019 Aug 19;19(1):58. doi: 10.1186/s40644-019-0246-0.
Source . Similar articles



HIGH-GRADE GLIOMAS


.

Xia Y, Liao W, Huang S, Liu Z, Huang X, Yang C, Ye C, Jiang Y, Wang J.
Nomograms for Predicting the Overall and Cancer-Specific Survival of Patients With High-Grade Glioma: A Surveillance, Epidemiology, and End Results Study.
Turk Neurosurg. 2019 May 17. doi: 10.5137/1019-5149.JTN.26131-19.2. [Epub ahead of print]
Source . Similar articles



.

Yerram P, Reiss SN, Modelevsky L, Gavrilovic IT, Kaley T.
Evaluation of toxicity of carmustine with or without bevacizumab in patients with recurrent or progressive high grade gliomas.
J Neurooncol. 2019 Aug 20. doi: 10.1007/s11060-019-03266-0. [Epub ahead of print]
Source . Similar articles



GLIOMATOSIS CEREBRI


.

Kwon MJ, Kang SY, Cho H, Lee JI, Kim ST, Suh YL.
Clinical relevance of molecular subgrouping of gliomatosis cerebri per 2016 WHO classification: A clinicopathological study of 89 cases.
Brain Pathol. 2019 Aug 21. doi: 10.1111/bpa.12782. [Epub ahead of print]
Source . Similar articles



LOW-GRADE GLIOMAS


.

Fukuya Y, Ikuta S, Maruyama T, Nitta M, Saito T, Tsuzuki S, Chernov M, Kawamata T, Muragaki Y.
Tumor recurrence patterns after surgical resection of intracranial low-grade gliomas.
J Neurooncol. 2019 Jul 30. doi: 10.1007/s11060-019-03250-8. [Epub ahead of print]
Source . Similar articles



DIFFUSE ASTROCYTIC AND OLIGODENDROGLIAL TUMORS



GLIOBLASTOMA


.

Altieri R, Melcarne A, Soffietti R, Rudá R, Franchino F, Pellerino A, La Rocca G, Sabatino G, Olivi A, Ducati A, Zeppa P, Tardivo V, Mantovani C, Chiovatero I, Martini S, Dolce P, Savastano R, Lanotte MM, Zenga F, Garbossa D.
Supratotal Resection of Glioblastoma: Is Less More?
Surg Technol Int. 2019 Aug 1;35. pii: sti35/1167. [Epub ahead of print]
Source . Similar articles



.

Chatzikonstantinou G, Ulrich P, Archavlis E, Zamboglou N, Strouthos I, Zoga E, Baltas D, Tselis N.
Interstitial high-dose-rate brachytherapy in the primary treatment of inoperable glioblastoma multiforme.
J Contemp Brachytherapy. 2019 Jun;11(3):215-220. doi: 10.5114/jcb.2019.85722. Epub 2019 Jun 28.
Source . Similar articles



.

Chen JC, Lee IN, Huang C, Wu YP, Chung CY, Lee MH, Lin MH, Yang JT.
Valproic acid-induced amphiregulin secretion confers resistance to temozolomide treatment in human glioma cells.
BMC Cancer. 2019 Aug 1;19(1):756. doi: 10.1186/s12885-019-5843-6.
Source . Similar articles



.

Davies J, Reyes-Rivera I, Pattipaka T, Skirboll S, Ugiliweneza B, Woo S, Boakye M, Abrey L, Garcia J, Burton E.
Survival in elderly glioblastoma patients treated with bevacizumab-based regimens in the United States.
Neurooncol Pract. 2018 Nov;5(4):251-261. doi: 10.1093/nop/npy001. Epub 2018 Feb 6.
Source . Similar articles



.

Hainsworth JD, Becker KP, Mekhail T, Chowdhary SA, Eakle JF, Wright D, Langdon RM, Yost KJ, Padula GDA, West-Osterfield K, Scarberry M, Shaifer CA, Shastry M, Burris HA 3rd, Shih K.
Phase I/II study of bevacizumab with BKM120, an oral PI3K inhibitor, in patients with refractory solid tumors (phase I) and relapsed/refractory glioblastoma (phase II).
J Neurooncol. 2019 Sep;144(2):303-311. doi: 10.1007/s11060-019-03227-7. Epub 2019 Aug 7.
Source . Similar articles



.

Kim EH, Jo Y, Sai S, Park MJ, Kim JY, Kim JS, Lee YJ, Cho JM, Kwak SY, Baek JH, Jeong YK, Song JY, Yoon M, Hwang SG.
Tumor-treating fields induce autophagy by blocking the Akt2/miR29b axis in glioblastoma cells.
Oncogene. 2019 Aug 2. doi: 10.1038/s41388-019-0882-7. [Epub ahead of print]
Source . Similar articles



.

Lahmi L, Idbaih A, Rivin Del Campo E, Hoang-Xuan K, Mokhtari K, Sanson M, Canova CH, Carpentier A, Jacob J, Maingon P, Feuvret L.
Whole brain radiotherapy with concurrent temozolomide in multifocal and/or multicentric newly diagnosed glioblastoma.
J Clin Neurosci. 2019 Oct;68:39-44. doi: 10.1016/j.jocn.2019.07.065. Epub 2019 Aug 6.
Source . Similar articles



.

Lee EQ, Muzikansky A, Duda DG, Gaffey S, Dietrich J, Nayak L, Chukwueke UN, Beroukhim R, Doherty L, Laub CK, LaFrankie D, Fontana B, Stefanik J, Ruland S, Caruso V, Bruno J, Ligon K, Reardon DA, Wen PY.
Phase II trial of ponatinib in patients with bevacizumab-refractory glioblastoma.
Cancer Med. 2019 Aug 24. doi: 10.1002/cam4.2505. [Epub ahead of print]
Source . Similar articles



.

Nguyen HT, Nguyen N, Liu LY, Dovek L, Lenchner D, Harris R, Ozer B, Ravelo A, Sommer N, Sim MS, Elashoff R, Green R, Nghiemphu PL, Cloughesy TF, Ellingson B, Lai A.
Bevacizumab at first recurrence after standard radio-chemotherapy is associated with improved overall survival in glioblastoma patients with large tumor burden.
Neurooncol Pract. 2019 Mar;6(2):103-111. doi: 10.1093/nop/npy021. Epub 2018 Sep 20.
Source . Similar articles



.

Yusuf MB, Gaskins J, Amsbaugh MJ, Woo S, Burton E.
Survival impact of prolonged postoperative radiation therapy for patients with glioblastoma treated with combined-modality therapy.
Neurooncol Pract. 2019 Mar;6(2):112-123. doi: 10.1093/nop/npy027. Epub 2018 Jul 20.
Source . Similar articles



bottom